# US 6,727,248 B2 · Substituted quinolinecarboxamides as antiviral agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,248 B2
- Document ID: US6727248B2
- Status: Granted
- Kind: B2
- Application number: 10/350,248
- Filed: 2003-01-23
- Published: 2003-08-07
- Granted: 2004-04-27
- Earliest claimed: 2001-03-01
- Assignees: Pharmacia & Upjohn Company
- Inventors: Valerie A. Vaillancourt; Audris Huang
- Web page: https://patentgrep.com/patent/US6727248B2

## CPC

- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A61P 31/12: Antivirals
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 215/48: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 233/56: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D 249/08: 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 413/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention discloses disubstiuted 4-oxo-1,4-dihydro-3-quinolinecarboxamide derivatives. The compounds are useful as antiviral agents, in particular, as agents against viruses of the herpes family.

## Claims

### Claim 1

N-(4-chlorobenzyl)-8-(3-hydroxy-1-propynyl)-1-methyl-6-(4-morpholinylmethyl)-4-oxo-1,4-dihydro-3-quinolinecarboxamide, or its pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

A pharmaceutical composition comprising a therapeutically effective amount of compound of claim 1 and a pharmaceutically acceptable carrier.

### Claim 3 (depends on 1)

A method of treating infections by herpesviruses, wherein said herpesviruses is herpes simplex virus types 1, herpes simplex virus types 2, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, human herpes viruses 6, human herpes viruses 7 or human herpes viruses, which comprises administering to an animal in need thereof a therapeutically effective amount of compound of claim 1.

### Claim 4 (depends on 3)

The method of claim 3 wherein said herpesviruses is human cytomegalovirus.

### Claim 5 (depends on 1, 3)

The method of claim 3 wherein the compound of claim 1 is administered orally, parenterally or topically.

### Claim 6 (depends on 1, 3)

The method of claim 3 wherein the compound of claim 1 is in an amount of from about 0.1 to about 300 mg/kg of body weight.

### Claim 7 (depends on 1, 3)

The method of claim 3, wherein the compound of claim 1 is in an amount of from about 1 to about 30 mg/kg of body weight.

### Claim 8 (depends on 3)

The method of claim 3, wherein the animal is mammal.

### Claim 9 (depends on 3)

The method of claim 3, wherein the animal is human.
